Literature DB >> 24018009

Main issues in micronutrient supplementation in phenylketonuria.

A M Lammardo1, M Robert, J C Rocha, M van Rijn, K Ahring, A Bélanger-Quintana, A MacDonald, K Dokoupil, H Gokmen Ozel, P Goyens, F Feillet.   

Abstract

For almost all patients with PKU, a low phenylalanine diet is the basis of the treatment despite a widely varying natural protein tolerance. A vitamin and mineral supplement is essential and it is commonly added to a phenylalanine-free (phe-free) source of L-amino acids. In PKU, many phe-free L-amino acid supplements have age-specific vitamin and mineral profiles to meet individual requirements. The main micronutrient sources are chemically derived and their delivery dosage is usually advised in three or more doses throughout the day. Within the EU, the composition of VM (vitamin and mineral) phe-free L-amino acid supplements is governed by the Foods for Special Medical Purposes (FSMP) directive (European Commission Directive number 1999/21/EC and amended by Directive 2006/141/EC). However the micronutrient composition of the majority fails to remain within FSMP micronutrient maximum limits per 100 kcal due to their low energy content and so compositional exceptions to the FSMP directive have to be granted for each supplement. All patients with PKU require an annual nutritional follow-up, until it has been proven that they are not at risk of any vitamin and mineral imbalances. When non-dietary treatments are used to either replace or act as an adjunct to diet therapy, the quality of micronutrient intake should still be considered important and monitored systematically. European guidelines are required about which micronutrients should be measured and the conditions (fasting status) for monitoring.
© 2013.

Entities:  

Keywords:  Micronutrients; Minerals; Phenylalanine; Phenylketonuria; Vitamins

Mesh:

Substances:

Year:  2013        PMID: 24018009     DOI: 10.1016/j.ymgme.2013.08.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.

Authors:  Kathryn E Coakley; Eric I Felner; Vin Tangpricha; Peter W F Wilson; Rani H Singh
Journal:  JIMD Rep       Date:  2017-01-28

2.  Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria.

Authors:  Serwet Demirdas; Francjan J van Spronsen; Carla E M Hollak; J Hanneke van der Lee; Peter H Bisschop; Fred M Vaz; Nienke M Ter Horst; M Estela Rubio-Gozalbo; Annet M Bosch
Journal:  Ann Nutr Metab       Date:  2017-03-24       Impact factor: 3.374

3.  Protein substitutes for phenylketonuria in Europe: access and nutritional composition.

Authors:  M J Pena; M F de Almeida; E van Dam; K Ahring; A Bélanger-Quintana; K Dokoupil; H Gokmen-Ozel; A M Lammardo; A MacDonald; M Robert; J C Rocha
Journal:  Eur J Clin Nutr       Date:  2016-04-27       Impact factor: 4.016

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile.

Authors:  Maria João Pena; Manuela Ferreira Almeida; Esther van Dam; Kirsten Ahring; Amaya Bélanger-Quintana; Katharina Dokoupil; Hulya Gokmen-Ozel; Anna Maria Lammardo; Anita MacDonald; Martine Robert; Júlio César Rocha
Journal:  Orphanet J Rare Dis       Date:  2015-12-22       Impact factor: 4.123

6.  Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle.

Authors:  Fernando Andrade; Olalla López-Suárez; Marta Llarena; María L Couce; Luis Aldámiz-Echevarría
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

7.  Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods.

Authors:  Bridget M Stroup; Denise M Ney; Sangita G Murali; Frances Rohr; Sally T Gleason; Sandra C van Calcar; Harvey L Levy
Journal:  J Nutr Metab       Date:  2017-12-31

8.  Reply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective?

Authors:  Júlio César Rocha; Conceição Calhau; Anita MacDonald
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-06-01       Impact factor: 4.310

9.  Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.

Authors:  María L Couce; Isidro Vitoria; Luís Aldámiz-Echevarría; Ana Fernández-Marmiesse; Iria Roca; Marta Llarena; Paula Sánchez-Pintos; Rosaura Leis; Alvaro Hermida
Journal:  Orphanet J Rare Dis       Date:  2016-09-09       Impact factor: 4.123

Review 10.  Dietary intervention in the management of phenylketonuria: current perspectives.

Authors:  Júlio César Rocha; Anita MacDonald
Journal:  Pediatric Health Med Ther       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.